FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Setanaxib, 1218942-37-0, Setanaxib Intermediate 10449-07-7, stock 451.2g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply.
Setanaxib, 1218942-37-0, Setanaxib Intermediate 1830-54-2, stock 234.9g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply.
Setanaxib, 1218942-37-0, Setanaxib Intermediate 1158233-60-3, stock 113.5g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply.
Setanaxib, 1218942-37-0, Setanaxib Intermediate 54263-82-0, stock 252.2g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply.
Setanaxib, 1218942-37-0, Setanaxib Intermediate /, stock 169.6g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply.
Setanaxib, 1218942-37-0, Setanaxib Intermediate 1640998-04-4, stock 254.1g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply.
Setanaxib, 1218942-37-0, Setanaxib Intermediate /, stock 362.7g, white powder, assay by HPLC 100%, HNMR, LCMS we supply.
